Shares of Surgery Partners Inc (NASDAQ:SGRY) have been given an average rating of “Hold” by the eight research firms that are currently covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $18.75.

Several equities research analysts have recently commented on SGRY shares. Zacks Investment Research upgraded Surgery Partners from a “sell” rating to a “hold” rating in a report on Wednesday, January 9th. BidaskClub upgraded Surgery Partners from a “hold” rating to a “buy” rating in a report on Saturday, March 16th. Finally, ValuEngine downgraded Surgery Partners from a “buy” rating to a “hold” rating in a report on Thursday, February 7th.

SGRY stock traded down $0.05 during mid-day trading on Monday, reaching $11.25. The company’s stock had a trading volume of 157,373 shares, compared to its average volume of 232,552. The company has a market cap of $570.49 million, a P/E ratio of -4.59 and a beta of 2.56. The company has a debt-to-equity ratio of 2.07, a quick ratio of 1.56 and a current ratio of 1.68. Surgery Partners has a 12 month low of $9.45 and a 12 month high of $19.95.

Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Wednesday, March 13th. The company reported ($0.74) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.01 by ($0.75). The business had revenue of $491.20 million during the quarter, compared to the consensus estimate of $485.35 million. Surgery Partners had a negative return on equity of 3.90% and a negative net margin of 11.45%. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.03) earnings per share. On average, research analysts predict that Surgery Partners will post -0.77 earnings per share for the current year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc boosted its position in shares of Surgery Partners by 1.2% during the third quarter. Vanguard Group Inc now owns 1,566,343 shares of the company’s stock valued at $25,845,000 after buying an additional 18,336 shares during the last quarter. Eaton Vance Management boosted its position in shares of Surgery Partners by 118.2% during the fourth quarter. Eaton Vance Management now owns 120,000 shares of the company’s stock valued at $1,175,000 after buying an additional 65,000 shares during the last quarter. Clearbridge Investments LLC boosted its position in shares of Surgery Partners by 4.6% during the third quarter. Clearbridge Investments LLC now owns 3,250,407 shares of the company’s stock valued at $53,632,000 after buying an additional 143,561 shares during the last quarter. Elk Creek Partners LLC boosted its position in shares of Surgery Partners by 17.9% during the fourth quarter. Elk Creek Partners LLC now owns 1,303,594 shares of the company’s stock valued at $12,762,000 after buying an additional 197,872 shares during the last quarter. Finally, AMI Asset Management Corp boosted its position in shares of Surgery Partners by 1.4% during the fourth quarter. AMI Asset Management Corp now owns 771,149 shares of the company’s stock valued at $7,550,000 after buying an additional 10,661 shares during the last quarter. Hedge funds and other institutional investors own 97.48% of the company’s stock.

About Surgery Partners

Surgery Partners, Inc, through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Further Reading: Percentage Decliners

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.